(Q44476921)

3 December 2017

title

Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase (English)

1 reference

3 December 2017

0 references

Hatem Tallima

1

1 reference

3 December 2017

Mona Montash

2

1 reference

3 December 2017

Pavel Veprek

3

1 reference

3 December 2017

Jiri Velek

4

1 reference

3 December 2017

Jan Jezek

5

1 reference

3 December 2017

Rashika El Ridi

6

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

21

1 reference

3 December 2017

issue

23

1 reference

3 December 2017

page(s)

3290-3300

1 reference

The search for a vaccine against schistosomiasis--a difficult path but an achievable goal

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Development of vaccines against human parasitic diseases: tools, current status and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to Schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Schistosoma mansoni: identification and protective immunity of adult worm antigens recognized by T lymphocytes of outbred Swiss mice immunized with irradiated cercariae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Identification of Schistosoma mansoni antigens recognized by T cells of C57BL/6 mice immunized with gamma-irradiated cercariae.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Production and characterization of monoclonal antibodies to anti-human chorionic somatomammotropin by immunization with two free synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Identifying strategies for immune intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

T cell responses are governed by avidity and co-stimulatory thresholds

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Recent advances in multiple antigen peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Complete sequence of the Schistosoma mansoni glyceraldehyde-3-phosphate dehydrogenase gene encoding a major surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Effector and regulatory mechanisms in immunity to schistosomes: a heuristic view

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. I. Evidence that the loss in susceptibility to immune damage undergone by developing schistosomula involves a change unrelated to t

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Why don't we have a schistosomiasis vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

Rapid appearance and asymmetric distribution of glucose transporter SGTP4 at the apical surface of intramammalian-stage Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

SPRM1lc, a heterodimeric amino acid permease light chain of the human parasitic platyhelminth, Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900180-4

7 January 2021

10.1016/S0264-410X(03)00180-4

Identifiers

DOI

1 reference

3 December 2017

1 reference